These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 92300)

  • 1. Resolution of block neutralization test curves into components of the foot-and-mouth disease virus system.
    Trautman R
    Arch Virol; 1979; 60(3-4):257-64. PubMed ID: 92300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization kinetics studies with type SAT2 foot-and-mouth disease virus strains. 1. Factors that influence the rate and pattern of neutralization.
    Rweyemamu MM; Booth JC; Pay TW
    J Hyg (Lond); 1977 Feb; 78(1):99-112. PubMed ID: 13123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationships in a microneutralization test for foot-and-mouth disease viruses.
    Booth JC; Rweyemamu MM; Pay TW
    J Hyg (Lond); 1978 Feb; 80(1):31-42. PubMed ID: 202650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between virus neutralization and serum protection bioassays for IgG and IgM antibodies to foot-and-mouth disease virus.
    Trautman R; Bennett CE
    J Gen Virol; 1979 Mar; 42(3):457-66. PubMed ID: 219135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
    Stave JW; Card JL; Morgan DO
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization kinetics studies with type SAT 2 foot-and-mouth disease virus strains.
    Rweyemamu MM; Booth JC; Parry N; Pay TW
    J Hyg (Lond); 1977 Jun; 78(3):429-38. PubMed ID: 68071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants.
    Stave JW; Card JL; Morgan DO; Vakharia VN
    Virology; 1988 Jan; 162(1):21-9. PubMed ID: 2827379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of cross reactions to foot-and-mouth disease virus in normal swine sera.
    Andersen AA
    Am J Vet Res; 1977 Nov; 38(11):1757-9. PubMed ID: 201197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of some immunological methods for the differentiation of strains of foot-and-mouth disease virus.
    Forman AJ
    J Hyg (Lond); 1975 Apr; 74(2):215-25. PubMed ID: 164500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
    Krebs O; Ahl R; Straub OC; Marquardt O
    Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactions of normal bovine serums to foot-and-mouth disease virus in plaque-reduction neutralization and radial immunodiffusion.
    Andersen AA
    Am J Vet Res; 1975 Jul; 36(7):979-83. PubMed ID: 167625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross reactions of normal bovine sera with foot-and-mouth disease virus: incidence, duration, and effect of shipping stress.
    Andersen AA
    Am J Vet Res; 1978 Apr; 39(4):603-6. PubMed ID: 206170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses.
    Rweyemamu MM; Pay TW; Parker MJ
    Dev Biol Stand; 1976; 35():205-4. PubMed ID: 198288
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
    Meloen RH; Rowlands DJ; Brown F
    J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the influence of the host system on the result of the neutralization of monodispersed and untreated foot- and mouth disease virus (author's transl)].
    GER ; Bauer K
    Zentralbl Bakteriol Orig A; 1975 Jun; 232(1):35-47. PubMed ID: 169651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unified mass-action theory for virus neutralization and radioimmunology.
    Trautman R
    Scand J Immunol; 1976; 5(6-7):609-22. PubMed ID: 185688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus.
    Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins.
    Meloen RH; Briaire J
    J Gen Virol; 1980 Nov; 51(Pt 1):107-16. PubMed ID: 6257830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
    Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of foot-and-mouth disease virus. II. Further parameters related to the sensitization of the 140S virion by antibody.
    Hardy MM; Moore DM
    J Gen Virol; 1982 Oct; 62 (Pt 2)():287-95. PubMed ID: 6292352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.